Altheus Therapeutics Inc., of Oklahoma City, said it completed dosing in ZA201, a double-blind, active-controlled phase II trial evaluating the efficacy and safety of Zoenasa rectal gel vs. mesalamine enema in 120 patients with left-sided ulcerative colitis.